D.Western Therapeutics Institute, Inc.
株式会社デ・ウエスタン・セラピテクス研究所
Valuation
Fundamental ratios for the latest reported period.
Ticker: 4576
FY2025 · 2025-12-31
| Gross margin | 90.0% |
| Operating margin | -159.9% |
| Net margin | -163.1% |
| Return on equity | -44.1% |
| Return on assets | -29.1% |
| Revenue growth (YoY) | -17.8% |
| EPS (basic) | ¥-13.19 |
| EPS growth (YoY) | — |
| Current ratio | 9.91x |
| Equity ratio | 66.1% |
| Book value / share | ¥26.44 |
| Free cash flow | -497 M |